Skip to main navigation
ARS Pharma
- ARS Pharma - Investor Relations
  • About Us
    • Meet Our Team
    • Careers
    • Job Openings
  • Product
    • neffy
      • neffy 2mg
      • neffyConnect
      • Prescribing information
    • Pipeline
    • Authorized Distributors
  • Investors & Media
    • Events & Presentations
    • Press Releases
    • Stock Information
      • Stock Quote & Chart
      • Analyst Coverage
    • Financials & Filings
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
      • Compliance Program
    • IR Resources
      • Email Alerts
    • Publications
    • Scientific Presentations
  • Community Program
    • neffyinSchools
  • Contact Us

SEC Filing Details

Document Details

Form
10-Q
Filing Date
Nov 5, 2026
Document Date
Sep 30, 2026
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
ARS Pharmaceuticals
Issuer
ARS PHARMACEUTICALS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
XML - XBRL INSTANCE DOCUMENT

©2026 ARS Pharmaceuticals Operations, Inc.  All rights reserved.  “ARS Pharma,” the ARS Pharma logo design, “neffy,” the neffy logo, and the neffyconnect logo are trademarks or registered trademarks of ARS Pharmaceuticals Operations, Inc. Generic references to ARS Pharma refer to ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) and/or its wholly-owned operations subsidiary,

Privacy Policy  |  Terms of Use

This site is intended for U.S. visitors only.